Pharmacotherapeutic follow-up in patients with type 1 diabetes in context of judicialization: possibility optimize costs
Abstract In Brazil, insulin analogs stand out as one of the most demanded medications by judicial means. However, the guarantee of judicial access does not guarantee rational use. In context, pharmacotherapeutic follow-up (PF) is shown to be clinical effective strategy for patients with diabetes. To...
Saved in:
Main Authors: | William Neves Oliveira (Author), Maurílio Souza Cazarim (Author), Thays Santos Mendonça (Author), Paulo Roque Obreli-Neto (Author), Mariana Linhares Pereira (Author), André Oliveira Baldoni (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patients in insulin analogues use via judicial litigation: do they use the Brazilian Public Health System (SUS)?
by: Thays Santos Mendonça, et al.
Published: (2023) -
Pacientes com diabetes mellitus tipo 2 em uso de medicamentos via judicial
by: Gustavo Costa Ferreira, et al.
Published: (2020) -
Profile of pharmaceutical interventions of a pharmacotherapeutic follow-up model for diabetic patients in a community pharmacy
by: William Lucas Ferreira da Silva, et al.
Published: (2022) -
Teaching-service partnership in the unified health system: implementation of outpatient pharmacotherapeutical follow-up
by: Marlon Silva Tinoco, et al.
Published: (2018) -
Broader Implications of Modeling and Simulation (M&S) Tools in Pharmacotherapeutic Decisions: A Cautionary Optimism
by: Ayyappa Chaturvedula, et al.
Published: (2020)